News and Events, Recent News

BriaCell Files a Patent Application for its Companion Diagnostic Platform to complement BriaVax™

Berkeley, CA and Vancouver, BC – November 29, 2016 – BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSXV: BCT) (OTCQB: BCTXF), a clinical-stage immuno-oncology company dedicated to the development of immuno-oncology treatments, is pleased to announce that it has filed a patent application with the U.S. Patent and Trademark Office (USPTO) as basis for potential […]

News and Events, Recent News

BriaCell Provides Clinical Development Update on BriaVax™

Berkeley, CA and Vancouver, BC – November 10, 2016 – BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSXV: BCT) (OTCQB: BCTXF), a clinical-stage immuno-oncology company dedicated to the development of immuno-oncology treatments that can enhance the lives of cancer patients, today provided a comprehensive clinical development update for BriaVax™, its proprietary vaccine for advanced breast […]